Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Lav Selarka, Suktara Sharma, Dinesh Kumar Saini, et al.
Mycoses (2021) Vol. 64, Iss. 10, pp. 1253-1260
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
Valliappan Muthu, Ritesh Agarwal, Atul Patel, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. e240-e253
Open Access | Times Cited: 67
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)
Jon Salmanton‐García, Wing‐Yan Au, Martin Hoenigl, et al.
International Journal of Antimicrobial Agents (2023) Vol. 61, Iss. 3, pp. 106718-106718
Open Access | Times Cited: 48
Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
Salman Hussain, Abanoub Riad, Ambrish Singh, et al.
Journal of Fungi (2021) Vol. 7, Iss. 11, pp. 985-985
Open Access | Times Cited: 66
An insight into endophytic antimicrobial compounds: an updated analysis
Shivani Digra, Skarma Nonzom
Plant Biotechnology Reports (2023) Vol. 17, Iss. 4, pp. 427-457
Open Access | Times Cited: 27
Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme
Laura Gouzien, Didier Che, Sophie Cassaing, et al.
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101010-101010
Open Access | Times Cited: 9
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals
Danila Seidel, Michaela Simon, Rosanne Sprute, et al.
Mycoses (2021) Vol. 65, Iss. 1, pp. 103-109
Open Access | Times Cited: 49
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India – a multi-centre study
Manisha Biswal, Parikshaa Gupta, Rimjhim Kanaujia, et al.
Journal of Hospital Infection (2022) Vol. 122, pp. 173-179
Open Access | Times Cited: 34
Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis
Atsuyuki Watanabe, Matsuo So, Hayato Mitaka, et al.
Mycopathologia (2022) Vol. 187, Iss. 2-3, pp. 271-289
Open Access | Times Cited: 31
Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why
Bishan Das Radotra, Sundaram Challa
Current Fungal Infection Reports (2022) Vol. 16, Iss. 4, pp. 206-220
Open Access | Times Cited: 31
Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients
Kerri Basile, Catriona Halliday, Jen Kok, et al.
Journal of Fungi (2022) Vol. 8, Iss. 1, pp. 58-58
Open Access | Times Cited: 27
Binary ethosomes for the enhanced topical delivery and antifungal efficacy of ketoconazole
Alhanouf A. Aljohani, Maryam A. Alanazi, Lujain A. Munahhi, et al.
OpenNano (2023) Vol. 11, pp. 100145-100145
Open Access | Times Cited: 20
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors
Anuradha Chowdhary, Nitesh Gupta, Sebastian Wurster, et al.
Mycoses (2023) Vol. 66, Iss. 6, pp. 515-526
Open Access | Times Cited: 17
COVID-19-associated mucormycosis in India: Why such an outbreak?
Grégoire Pasquier
Journal de Mycologie Médicale (2023) Vol. 33, Iss. 3, pp. 101393-101393
Open Access | Times Cited: 17
Antifungal Policy and Practice Across Five Countries: A Qualitative Review
David W. Denning, John R. Perfect, Neda Milevska Kostova, et al.
Journal of Fungi (2025) Vol. 11, Iss. 2, pp. 162-162
Open Access
Evaluating Risk Factors for COVID-19-associated Mucormycosis: Insights from a Case Series
Shefali Gautam, Shashank Kumar, Shreya Mahesh, et al.
(2025) Vol. 1, Iss. 2, pp. 29-31
Closed Access
Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 – A Preliminary Report from a Single Hospital
Ritu Arora, Ruchi Goel, Samreen Khanam, et al.
Clinical ophthalmology (2021) Vol. Volume 15, pp. 3505-3514
Open Access | Times Cited: 39
COVID-19 and Plethora of Fungal Infections
Reetu Kundu, Nidhi Singla
Current Fungal Infection Reports (2022) Vol. 16, Iss. 2, pp. 47-54
Open Access | Times Cited: 22
Incidence and Mortality of COVID-19-Associated Invasive Fungal Infections Among Critically Ill Intubated Patients: A Multicenter Retrospective Cohort Analysis
Julio C Zuniga-Moya, Benjamin Papadopoulos, Armaghan‐e‐Rehman Mansoor, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 4
COVID-19-Associated Pulmonary Mucormycosis
Vidya Krishna, N.K. Bansal, Jaymin B. Morjaria, et al.
Journal of Fungi (2022) Vol. 8, Iss. 7, pp. 711-711
Open Access | Times Cited: 20
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
Laura C. García-Carnero, Héctor M. Mora‐Montes
Journal of Fungi (2022) Vol. 8, Iss. 5, pp. 445-445
Open Access | Times Cited: 18
Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies
Nuobing Yang, Lining Zhang, Sizhou Feng
Journal of Fungi (2023) Vol. 9, Iss. 5, pp. 592-592
Open Access | Times Cited: 10
Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies
Ram Kumar Sahu, Mounir M. Salem‐Bekhit, Bedanta Bhattacharjee, et al.
Antibiotics (2021) Vol. 10, Iss. 9, pp. 1079-1079
Open Access | Times Cited: 24
Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India
Ameet Dravid, Reema Kashiva, Zafer Khan, et al.
Mycoses (2022) Vol. 65, Iss. 5, pp. 526-540
Open Access | Times Cited: 17
COVID-19-associated mucormycosis of head-and-neck region: A systematic review.
Mamata Kamat, Uma Datar, Sanjay Byakodi, et al.
PubMed (2022) Vol. 8, Iss. 1, pp. 31-42
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top